US Patent Issued to Celyntra Therapeutics, DANMARKS TEKNISKE UNIVERSITET on Jan. 20 for "CRISPR systems with engineered dual guide nucleic acids" (Danish, American Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,529,076, issued on Jan. 20, was assigned to Celyntra Therapeutics SA (Mont-Saint-Guibert, Belgium) and DANMARKS TEKNISKE UNIVERSITET (Kgs. Lyngby, Denmark).

"CRISPR systems with engineered dual guide nucleic acids" was invented by Ryan T. Gill (Denver), Tanya Warnecke (Boulder, Colo.), Andrea Barghetti (Cophenhagen, Denmark) and Line Dahl Poulsen (Ballerup, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an engineered Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) system comprising engineered dual guide nucleic acids (e.g., RNAs) capable of activating a CRISPR-Associated (Cas) nuclease, such as...